Report overview
A?brain tumor?is a mass or growth of abnormal cells in your brain. Many different types of?brain tumors?exist.?
This report contains market size and forecasts of Targeted Therapy for Brain Cancer in global, including the following market information:
Global Targeted Therapy for Brain Cancer Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Targeted Therapy for Brain Cancer Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Targeted Therapy for Brain Cancer companies in 2022 (%)
The global Targeted Therapy for Brain Cancer market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Belzutifan (Welireg) Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Targeted Therapy for Brain Cancer include Merck & Co., Roche and Novartis, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Targeted Therapy for Brain Cancer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Therapy for Brain Cancer Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Targeted Therapy for Brain Cancer Market Segment Percentages, by Type, 2022 (%)
Belzutifan (Welireg)
Bevacizumab (Avastin)
Everolimus (Afinitor)
Global Targeted Therapy for Brain Cancer Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Targeted Therapy for Brain Cancer Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Targeted Therapy for Brain Cancer Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Targeted Therapy for Brain Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Therapy for Brain Cancer revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Targeted Therapy for Brain Cancer revenues share in global market, 2022 (%)
Key companies Targeted Therapy for Brain Cancer sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Targeted Therapy for Brain Cancer sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co.
Roche
Novartis
